Who Owns ZYN? Swedish Match, Philip Morris and Where ZYN Is Made
Short answer: ZYN is owned by Philip Morris International (PMI). The brand was created by the Swedish snus company Swedish Match, which PMI took over in November 2022 in a deal worth about $16 billion. In the US, ZYN is made by Swedish Match USA — a PMI affiliate — at plants in Owensboro, Kentucky and Aurora, Colorado.
Who created ZYN?
ZYN is a Swedish Match brand; no source we have found shows it was bought as an existing brand. According to Swedish Match USA’s own presentation to the FDA’s advisory committee, ZYN was test-launched in 50 stores in Colorado in 2014, expanded to 11 western states in 2016 — more than 4,000 stores by November that year — and launched nationally in the US in 2019.
Swedish Match and PMI have not publicly named an inventor. Inc. magazine, however, describes the Swedish chemist Thomas Ericsson as “the inventor of Zyn”, saying he developed a white snus formula in his garage and that Swedish Match approached him in 2009 about bringing his white nicotine pouch to market. We have not seen that confirmed by Swedish Match or PMI. Ericsson now advises challenger brands — see private capital outside Big Tobacco. It is also worth correcting a common claim: ZYN was not the first nicotine pouch, even though Swedish Match’s 2016 press release called it that. The format had existed in Sweden since the late 2000s as a medicinal product — see when nicotine pouches were invented.
How Philip Morris came to own ZYN
PMI announced its offer for Swedish Match on May 11, 2022 at SEK 106 per share. On October 20, 2022 it raised the offer to SEK 116 per share — stated as final — valuing the company at roughly SEK 176 billion, widely reported as about $16 billion. On November 7, 2022 the offer became unconditional with PMI owning 82.59% of the shares; by November 28 it had passed 93% and started a compulsory buyout of the rest. Swedish Match’s last trading day on Nasdaq Stockholm was December 30, 2022.
Who makes ZYN today?
In the FDA’s marketing authorizations, the applicant and manufacturer of record for ZYN is Swedish Match USA, Inc., a PMI affiliate. Since January 1, 2026, PMI has been organized into two business units, PMI International and PMI U.S., with the US reported as a separate segment and Stacey Kennedy as CEO of PMI U.S.
Where is ZYN made?
| Location | What we know | Status |
|---|---|---|
| Owensboro, Kentucky | Swedish Match plant since 1973. A $232 million expansion with 450 jobs was announced on August 27, 2024, with planned completion in Q2 2025. | Operating |
| Aurora, Colorado | Announced on July 16, 2024 as a $600 million, 500-job project. Now a $1.2 billion investment over 2024–2028; commercial production began in July 2026, and the plant will also supply Asia, Latin America and the Caribbean. | Operating since July 2026 |
| Sweden and Denmark | Swedish Match reported in 2021 that its nicotine pouches were made in the US, Sweden and Denmark. Its plant in Silkeborg, Denmark produces nicotine pouches. | Which European plant makes ZYN is not specified in the sources we have checked |
You will find sites that name one specific Swedish factory as “the ZYN plant”. We have not been able to verify that against a primary source, so we don’t repeat it.
How big is ZYN?
PMI shipped 794 million cans of ZYN in 2025 and says ZYN held about two-thirds of US nicotine pouch category value that year; the brand is sold in 55 markets. In the second quarter of 2026, PMI switched to reporting individual pouches: 2.9 billion pouches shipped in the US, up about 2% on the year. On the regulatory side, ZYN received the FDA’s first-ever marketing authorization for nicotine pouches (20 products, January 16, 2025), modified risk orders for the same 20 products on June 30, 2026, and authorization for 11 ZYN Ultra products at 9 and 11 mg on August 21, 2026.
Can you invest in ZYN?
Not directly. ZYN has no ticker of its own; the way to own it is through Philip Morris International, listed on the New York Stock Exchange as PM.
Our read ZYN’s value rests less on the recipe than on two assets that are hard to copy: FDA authorization and manufacturing capacity. The 2024–2025 shortage showed what happens when demand outruns capacity, and the PMTA process shows how narrow the regulatory gate is. PMI didn’t pay $16 billion for a flavor — it paid for a position few competitors can reach quickly.
What it means for you
- Value in this category is regulatory and industrial, not just brand. Authorization and reliable supply are what an acquirer prices — build for both from the start.
- Big tobacco buys traction. ZYN is the largest example, but far from the only one — see our ownership map of the nicotine pouch brands.
- Don’t compete with ZYN on its own terms. Head-on brand competition against a player with this capacity is expensive; availability, niches and channels are where challengers win.
We help brands find the channels and markets where they can actually win — see market, channels and data.
Sources
- Why founders court the inventor of Zyn, 20 November 2025 — Inc.
- ZYN advisory committee presentation by Swedish Match USA (ZYN history slide), January 2026 — FDA
- Swedish Match announces market expansion of ZYN, 7 November 2016 — PR Newswire
- PMI announces final offer of SEK 116 per Swedish Match share, 20 October 2022 — Business Wire
- PMHH completes its offer and becomes owner of 82.59% of Swedish Match, 7 November 2022 — Cision
- Delisting of Swedish Match AB — MFN
- Philip Morris International evolves organizational model, 3 November 2025 — Business Wire
- Swedish Match expansion in Owensboro, 27 August 2024 — Commonwealth of Kentucky
- PMI U.S. affiliate to invest $600 million in Aurora, Colorado, 16 July 2024 — Business Wire
- Opening of the Aurora, Colorado facility, 27 July 2026 — Business Wire
- Swedish Match Annual Report 2021
- PMI 2025 fourth-quarter and full-year results, 5 February 2026 — Business Wire
- FDA authorizes marketing of 20 ZYN nicotine pouch products, 16 January 2025 — FDA
- FDA authorizes 20 ZYN nicotine pouches to be marketed with a modified risk claim — FDA
- FDA authorizes 11 new nicotine pouches (ZYN Ultra), 21 August 2026 — FDA
Want help turning this into action for your business?
Book an initial call